FDA Coupon Clippers Get To Work, Refine Study On Drug Discounts
This article was originally published in The Pink Sheet Daily
Executive Summary
The agency is going ahead with plans to examine how money-saving offers affect consumer perceptions of drug ads.
You may also be interested in...
FDA's Office of Medical Policy Grows Into A "Super Office"; DDMAC Gets A Promotion
The Office of Medical Policy now houses the Office of Prescription Drug Promotion (formerly DDMAC) and the newly created Office of Medical Policy Initiatives.
FDA’s DTC Coupon Study Triggers First Amendment Objections From PhRMA
FDA’s third attempt at studying the effects of coupons in direct-to-consumer print advertising triggers First Amendment concerns and raises the specter of regulatory restrictions based upon “potential deception,” according to the Pharmaceutical Research and Manufacturers of America.
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.